Le Lézard
Classified in: Health
Subject: RCL

/C O R R E C T I O N from Source -- Canadian Food Inspection Agency (CFIA)/


In the news release, Food Recall Warning - Various poppy seeds recalled due to Salmonella, issued 14-Apr-2022 by the Canadian Food Inspection Agency (CFIA) over CNW, we are advised that this release has been amended to correctly identify affected lots for Moulin Abénakis brand Organic Poppy Seeds. The complete, corrected release follows:

Food Recall Warning - Various poppy seeds recalled due to Salmonella

OTTAWA, ON, April 14, 2022 /CNW/ -

Summary
Affected products

Brand

Product

Size

UPC

Codes

Distribution

None

Poppy Seeds

300 g

6 28384 90432 7

Lot #
112033113-07
12/16

Sold at:

Oak Manor Organic,
756907 Oxford County Road #5,
Tavistock (Ontario)

None

Organic Poppy
Seeds

Variable

None

All packages
sold from May 21, 2021 to
April 13, 2022 inclusively

Sold at:

Sunnyside Natural Market,
338 - 10th Street NW, Unit 10,
Calgary (Alberta)

Moulin
Abénakis

Organic Poppy
Seeds

400 g

0 67486 10904 7

All lots starting with 20 or 21

Sold in Quebec, Ontario,
New Brunswick and
may have been distributed in
other provinces and territories

Grainworks

Organic Poppy
Seeds

500 g

6 27544 10863 6

Lot # 7788-08

Sold in Alberta and British
Columbia and online

Grainworks

Organic Poppy
Seeds

1.5 kg

6 27544 10864 3

Lot # 7788-08

 

Sold in Alberta and British
Columbia and online

Grainworks

Organic Poppy
Seeds

11.34 kg

6 27544 10862 9

Lot # 7788-08

Sold in Alberta and British
Columbia and online

Issue

Industry is recalling various poppy seeds from the marketplace due to possible Salmonella contamination.

The recalled products have been sold as indicated in the table.

What you should do

Food contaminated with Salmonella may not look or smell spoiled but can still make you sick. Young children, pregnant women, the elderly and people with weakened immune systems may contract serious and sometimes deadly infections. Healthy people may experience short-term symptoms such as fever, headache, vomiting, nausea, abdominal cramps and diarrhea. Long-term complications may include severe arthritis.

Learn more:

Background

This recall was triggered by the Canadian Food Inspection Agency's inspection activities.

There have been no reported illnesses associated with the consumption of these products.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated food recall warnings.

The CFIA is verifying that industry is removing the recalled products from the marketplace.

Également disponible en français

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 06:39
The global pre-filled syringes market size is estimated to grow by USD 3512.4 million from 2023-2027, according to Technavio. The market is estimated to grow at a CAGR of almost 8.93% during the forecast period....

at 06:30
ConcertAI, the leader in oncology predictive and generative AI SaaS Solutions and Real-World Data for healthcare and life sciences, today announced that Dhiraj Carumbaya has joined the company as Senior Vice President and General Manager of the...

at 06:05
Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced that Chief Judge Connolly of the U.S. District Court in Delaware issued an opinion in the patent litigation brought by Magnolia Medical, Inc. finding...

at 06:02
SOPHiA GENETICS , a cloud-native software company and a leader in data-driven medicine, today announced that Klinikum Klagenfurt am Wörthersee, the third largest hospital in Austria, is live on the SOPHiA DDMtm Platform. The hospital will use SOPHiA...

at 06:00
Accenture has made a strategic investment, through Accenture Ventures, in Turbine, a predictive simulation company that is building a platform for interpreting human biology. Accenture's investment will help Turbine further extend its capabilities...

at 06:00
M42 has achieved the Global Healthcare Accreditation (GHA) certification for Excellence in Medical Travel Patient Experience from the US for its pioneering approach. With an overall score of 91 per cent, this certification reaffirms M42's commitment...



News published on and distributed by: